

Michele Bratcher Goodwin
Dr. Michele Bratcher Goodwin is advancing the conversation in bioethics, biotechnology, and health law through her interdisciplinary research and teaching. As a Senior Lecturer at Harvard Medical School and a Chancellor's Professor at the University of California, Irvine, she brings a wealth of knowledge and experience to her students and colleagues. Dr. Goodwin's work is recognized internationally, and she is an elected member of prestigious organizations such as the Hastings Center, the American Law Institute, and the American Bar Foundation. Her research interests span a wide array of critical issues, including bioethics, biotechnology, law, human trafficking, race and bioethics, and health law. Dr. Goodwin is the founding director of the Center for Biotechnology and Global Health Policy, where she leads initiatives that address pressing global health challenges. Her field research has taken her across continents, including Asia, Africa, Europe, and North America, providing her with a unique perspective on the intersection of law, ethics, and health. Dr. Goodwin is a prolific author, having written six books and over 100 articles, essays, book chapters, and commentaries. Her scholarly work has contributed significantly to the discourse on race, gender, and health policy, and she is frequently sought after for her expertise in these areas. Her contributions to academia and public policy continue to influence and inspire new generations of scholars and practitioners. Through her teaching and research, Dr. Goodwin is committed to fostering a deeper understanding of the ethical and legal dimensions of biotechnology and health care. Her dedication to advancing knowledge in these fields makes her a leading voice in the ongoing dialogue about the future of health and human rights.
Publications
, 2018-11-01
, 2017-11-24
, 326-331, 2015-01-01
, 289-292, 2015-01-01
, 190-202, 2024-07-01
, 371-380, 2016-01-01
, 189-224, 2017-01-26
, 363-384, 2006-09-01
, 113, 2021-01-01
, 73-74, 2022-01-01